Up-regulation of AGS3 during morphine withdrawal promotes cAMP superactivation via adenylyl cyclase 5 and 7 in rat nucleus accumbens/striatal neurons

Molecular Pharmacology

Volumn 76, Issue 3, 2009, Pages 526-533

  Fan, Peidong ^a   Jiang, Zhan ^a   Diamond, Ivan ^a,b   Yao, Lina ^a  

^a GILEAD SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATOR OF G PROTEIN SIGNALING 3; ADENOSINE A2A RECEPTOR; ADENYLATE CYCLASE; ADENYLATE CYCLASE 5; ADENYLATE CYCLASE 7; BINDING PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA1 SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA GAMMA SUBUNIT; MORPHINE; PHOSPHOLIPASE C; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG WITHDRAWAL; ENZYME ACTIVATION; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RAT;

ADENYLATE CYCLASE; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CORPUS STRIATUM; CYCLIC AMP; ISOENZYMES; MORPHINE; NEURONS; NUCLEUS ACCUMBENS; PROTEIN KINASE C-EPSILON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; SUBSTANCE WITHDRAWAL SYNDROME; UP-REGULATION;

EID: 69549098266     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.057802     Document Type: Article

References (40)

1. Arolfo MP, Yao L, Gordon AS, Diamond I, and Janak PH (2004) Ethanol operant self-administration in rats is regulated by adenosine A2 receptors. Alcohol Clin Exp Res 28:1308-1316. (Pubitemid 39238288)
2. Avidor-Reiss T, Bayewitch M, Levy R, Matus-Leibovitch N, Nevo I, and Vogel Z (1995) Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 270:29732-29738. (Pubitemid 3017003)
3. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, and Vogel Z (1996). Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbeta-gamma. J Biol Chem 271:21309-21315. (Pubitemid 26292991)
4. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M, and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-5047. (Pubitemid 27090057)
5. Blumer JB, Smrcka AV, and Lanier SM (2007) Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol Ther 113:488-506.
6. Bowers MS, Hopf FW, Chou JK, Guillory AM, Chang SJ, Janak PH, Bonci A, and Diamond I (2008) Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma. Proc Natl Acad Sci U S A 105:12533-12538.
7. Bowers MS, Lake RW, McFarland K, Peterson YK, Lanier SM, Lapish CC, and Kalivas PW (2003) AGS3: a G-protein regulator of addiction-associated behaviors. Ann N Y Acad Sci 1003:356-357. (Pubitemid 38083070)
8. Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC, Gregory ML, Lanier SM, and Kalivas PW (2004) Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron 42:269-281. (Pubitemid 38501649)
9. Brundege JM and Williams JT (2002) Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment. J Neurophysiol 87:1369-1375.
10. Chakrabarti S and Gintzler AR (2007) Phosphorylation of Galphas influences its association with the micro-opioid receptor and is modulated by long-term morphine exposure. Molecular pharmacology 72:753-760. (Pubitemid 47347310)
11. Chao J and Nestler EJ (2004) Molecular neurobiology of drug addiction. Annu Rev Med 55:113-132.
12. De Vries L, Fischer T, Tronchère H, Brothers GM, Strockbine B, Siderovski DP, and Farquhar MG (2000) Activator of G protein signaling 3 is a guanine dissociation inhibitor for Galpha i subunits. Proc Natl Acad Sci U S A 97:14364-14369. (Pubitemid 32016581)
13. Defer N, Best-Belpomme M, and Hanoune J (2000) Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol 279:F400-F416.
14. Dohrman DP, Diamond I, and Gordon AS (1996) Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus. Proc Natl Acad Sci U S A 93:10217-10221. (Pubitemid 26314602)
15. Gautam N, Downes GB, Yan K, and Kisselev O (1998) The G-protein betagamma complex. Cell Signal 10:447-455.
16. Kaplan GB and Leite-Morris KA (1997) Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Research 763:215-220.
17. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ, and Ishikawa Y (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269:16554-16558. (Pubitemid 24200406)
18. Kim KS, Lee KW, Lee KW, Im JY, Yoo JY, Kim SW, Lee JK, Nestler EJ, and Han PL (2006) Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. Proc Natl Acad Sci U S A 103:3908-3913.
19. Kimple RJ, Kimple ME, Betts L, Sondek J, and Siderovski DP (2002) Structural determinants for GoLoco-induced inhibition of nucleotide release by Galpha subunits. Nature 416:878-881. (Pubitemid 34453747)
20. Kull B, Svenningsson P, and Fredholm BB (2000) Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol Pharmacol 58:771-777. (Pubitemid 30761292)
21. Narita M, Funada M, and Suzuki T (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89:1-15. (Pubitemid 32367880)
22. Narita M, Makimura M, Feng Y, Hoskins B, and Ho IK (1994) Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res 650:175-179. (Pubitemid 24207062)
23. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
24. Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
25. O'Brien CP (2005) Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 162:1423-1431.
26. Olive MF and Messing RO (2004) Protein kinase C isozymes and addiction. Mol Neurobiol 29:139-154.
27. Peterson YK, Hazard S 3rd, Graber SG, and Lanier SM (2002) Identification of structural features in the G-protein regulatory motif required for regulation of heterotrimeric G-proteins. J Biol Chem 277:6767-6770.
28. Sahraei H, Motamedi F, Khoshbaten A, and Zarrindast MR (1999) Adenosine A(2) receptors inhibit morphine self-administration in rats. Eur J Pharmacol 383:107-113.
29. Sharma SK, Klee WA, and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci U S A 72:3092-3096.
30. Shippenberg TS, LeFevour A, and Chefer VI (2008) Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. CNS Neurol Disord Drug Targets 7:442-453.
31. Soria G, Castañé A, Berrendero F, Ledent C, Parmentier M, Maldonado R, and Valverde O (2004) Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC. Eur J Neurosci 20:2203-2213. (Pubitemid 39331141)
32. Takesono A, Cismowski MJ, Ribas C, Bernard M, Chung P, Hazard S 3rd, Duzic E, and Lanier SM (1999) Receptor-independent activators of heterotrimeric G-protein signaling pathways. J Biol Chem 274:33202-33205.
33. Tang WJ and Gilman AG (1991) Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science 254:1500-1503.
34. Watts VJ (2002) Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther 302:1-7.
35. Watts VJ and Neve KA (2005) Sensitization of adenylate cyclase by Galpha i/ocoupled receptors. Pharmacol Ther 106:405-421.
36. Weisberg SP and Kaplan GB (1999) Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse. Neuroscience Letters 264:89-92.
37. Yao L, Arolfo MP, Dohrman DP, Jiang Z, Fan P, Fuchs S, Janak PH, Gordon AS, and Diamond I (2002) betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell 109:733-743. (Pubitemid 34722269)
38. Yao L, Fan P, Jiang Z, Gordon A, Mochly-Rosen D, and Diamond I (2008) Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol Pharmacol 73:1105-1112.
39. Yao L, McFarland K, Fan P, Jiang Z, Inoue Y, and Diamond I (2005) Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. Proc Natl Acad Sci U S A 102:8746-8751. (Pubitemid 40862806)
40. Yao L, McFarland K, Fan P, Jiang Z, Ueda T, and Diamond I (2006) Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc Natl Acad Sci U S A 103:7877-7882. (Pubitemid 43752874)